REMICADE

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States

Active ingredients

The drug REMICADE contains one active pharmaceutical ingredient (API):

1 Infliximab UNII B72HH48FLU - INFLIXIMAB

Infliximab is a chimeric human-murine monoclonal antibody that binds with high affinity to both soluble and transmembrane forms of TNFα but not to lymphotoxin α (TNFβ). Read about Infliximab

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L04AB02	Infliximab	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AB Tumor necrosis factor alpha (TNF-α) inhibitors
Discover more medicines within L04AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10057H, 10067W, 10184B, 10196P, 11389K, 11399Y, 11412P, 11424G, 11445J, 11448M, 11459D, 11481G, 11482H, 11487N, 11489Q, 11497D, 11498E, 11590B, 11606W, 11797X, 4284L, 5753T, 5754W, 5755X, 5756Y, 5757B, 5758C, 6397Q, 6448J, 6496X, 9612X, 9613Y, 9617E, 9654D, 9674E
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 514512080025214
Country: CA	Health Products and Food Branch	Identifier(s): 02244016
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00067808, 00072181, 00200213, 00200236, 01359648, 01359654, 01557414, 01574335, 02001630, 02001653, 02144565, 02144571, 02645356, 02645362, 03332091, 03572300, 03572317, 03741240, 03767883, 04113876, 05461591, 05497293, 05497301, 05515795, 05515803, 05874034, 05874040, 06105800, 06105817, 06113343, 06140110, 06407180, 06453607, 06464752, 06464769, 06561395, 06561403, 06765778, 06939959, 07510371, 07796404, 08453557, 08453563, 08453586, 08453592, 09094876, 09245140, 10709231, 10822631, 10978899, 10985942, 11022507, 11024185, 11072511, 11078353, 11098580, 12444400, 12444417, 13582908, 14227434, 14259948, 14259954, 14277656, 15390053, 15390076, 15390082, 15390099, 15390107, 15433911, 15433928, 15433934, 15559919, 15658165, 15658171, 15658188, 15658194, 16383233, 16451822, 16451845, 16667367, 16743737, 16743743, 16743766, 16830092, 16830100
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 57-MBE-0516
Country: EE	Ravimiamet	Identifier(s): 1010833, 1111116, 1111127, 1430648, 1430659
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 99116001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 063187, 575787
Country: FR	Base de données publique des médicaments	Identifier(s): 64542736
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 392468, 43981
Country: HK	Department of Health Drug Office	Identifier(s): 54964
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4184
Country: IT	Agenzia del Farmaco	Identifier(s): 034528012
Country: JP	医薬品医療機器総合機構	Identifier(s): 2399402F1026
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1007116, 1030651, 1030652, 1036689, 1036690
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 54542
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 8822
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100104274
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W57617001, W57617002, W57617003, W57617004, W57617005
Country: SG	Health Sciences Authority	Identifier(s): 12120P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 1923011H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699636790380
Country: US	FDA, National Drug Code	Identifier(s): 57894-030